Table 2.

Summary of Patients Meeting Diabetes Quality Indicators by EPCD Period

Group and IndicatorPreimplementation: Patients Meeting IndicatorPostimplementation: Patients Meeting IndicatorP Valueb
Aug 2018, %Feb 2019, %IRRa (P Value)May 2019, %Mar 2020, %IRRa (P Value)
EPCD staff
   D5 indicator42.742.30.995 (.11)42.945.01.005 (.001).01
   Glycemic control67.967.80.997 (.26)66.867.31.001 (.75).45
   BP control74.770.80.989 (<.001)70.873.61.005 (<.001)<.001
   LDL-C control90.490.71.001 (.84)90.791.91.002 (.18).61
   Aspirin use94.494.91.000 (.89)92.794.50.998 (.65).73
   Tobacco free86.087.91.002 (.36)87.885.30.997 (.03).05
EPCD trainee
   D5 indicator36.937.00.999 (.86)38.942.01.011 (.003).14
   Glycemic control64.564.10.997 (.38)62.764.61.003 (.27).29
   BP control70.468.20.992 (.02)69.473.01.006 (.01).01
   LDL-C control90.891.20.998 (.81)90.692.71.003 (.24).52
   Aspirin use95.196.10.999 (.75)94.796.31.002 (.78).79
   Tobacco free81.083.81.003 (.44)83.982.60.998 (.73).38
Non-EPCD staff
   D5 indicator35.435.21.001 (.79)36.235.50.994 (<.001).05
   Glycemic control62.862.61.002 (.39)63.360.80.995 (<.001).01
   BP control70.467.90.995 (.01)68.669.51.000 (.91).02
   LDL-C control86.686.81.000 (.82)87.089.01.002 (.04).40
   Aspirin use91.791.31.000 (.93)91.492.81.001 (.78).91
   Tobacco free79.480.21.003 (.10)81.379.10.997 (<.001).01
  • BP = blood pressure; D5 = all 5 diabetes components (glycemic control, BP control, LDL-C control, aspirin use if indicated, and tobacco-free status); EPCD = Enhanced Primary Care Diabetes; IRR = incident rate ratio; LDL-C = low-density lipoprotein cholesterol.

  • a The IRR is the change in slope (monthly change in percentage of patients meeting the indicator).

  • b For comparison of IRRs between periods.